New Delhi, June 1 -- The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has fixed the retail prices of 30 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013.

The order was issued under Paragraphs 5, 11 and 15 of the DPCO, 2013. The notified retail prices are exclusive of Goods and Services Tax (GST), where applicable, and apply to the specific manufacturers and marketing companies mentioned in the notification.

The newly priced formulations cover a wide range of therapeutic segments, including diabetes management, cardiovascular diseases, nutritional supplements, antibiotics, hormonal medicines, pain management, gastrointestinal dis...